Epicardial Delivery of XC001 Gene Therapy to Promote Angiogenesis in CAD Patients Undergoing Treatment With CABG
Clinical trial NCT07118449 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07118449
- Sponsor
- XyloCor Therapeutics, Inc.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-27
- Primary completion
- 2026-12-30
- Enrollment
- 116
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.